Sort By: Published Date Updated Date Title ID Descending Ascending
The invention relates in one aspect to a therapeutic method to treat hemolytic uremic syndrome by administering to an individual a therapeutically effective amount of monoclonal antibody which binds specifically to either Shiga toxin, Shiga like toxin I or Shiga like toxin II. The hemolytic uremic syndrome is typically caused by an Enterohemorrhagic...
Published: 11/25/2022
Inventor(s): Saul Tzipori, Ramaswamy Balakrishnan, Arthur Donohue-Rolfe
Keywords(s):
Category(s): Therapeutic
Get to know us better.